Adamis Pharmaceuticals Historical PE Ratio image   This ADMP PE ratio history page last updated 8/15/2023
Adamis Pharmaceuticals Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q1 2023
5/15/2023
4.90-4.20-16.80NA
Q4 2022
3/16/2023
8.40-2.10-8.40NA
Q3 2022
11/14/2022
12.60-2.10-8.40NA
Q2 2022
8/10/2022
25.90-4.20-16.80NA
Q1 2022
5/16/2022
32.20-4.90-19.60NA
Q4 2021
3/31/2022
39.90-3.50-14.00NA
Q1 2021
11/22/2021
61.60-8.40-33.60NA
Q4 2020
4/15/2021
51.80-16.80-67.20NA
Q3 2020
11/9/2020
50.40-7.00-28.00NA
Q2 2020
8/17/2020
65.80-10.50-42.00NA
Q1 2020
5/18/2020
39.90-7.70-30.80NA
Q4 2019
3/30/2020
25.90-5.60-22.40NA
Q3 2019
11/12/2019
64.40-8.40-33.60NA
Q2 2019
8/8/2019
67.90-11.20-44.80NA
Q1 2019
5/9/2019
151.20-13.30-53.20NA
Q4 2018
3/15/2019
189.70-19.60-78.40NA
Q3 2018
11/9/2018
194.60-14.70-58.80NA
Q2 2018
8/10/2018
227.50-20.30-81.20NA
Q1 2018
5/10/2018
268.10-16.10-64.40NA
Q4 2017
3/16/2018
269.50-16.80-67.20NA
Q3 2017
11/14/2017
325.50-14.70-58.80NA
Q2 2017
8/14/2017
339.50-13.30-53.20NA
Q1 2017
5/12/2017
262.50-18.20-72.80NA
Q4 2016
3/30/2017
297.504.2016.8017.7
Q3 2016
11/14/2016
203.00-28.70-114.80NA
Q2 2016
8/15/2016
185.50-25.90-103.60NA
Q1 2016
5/13/2016
570.50-33.60-134.40NA
Q4 2015
2/27/2016
NA-14.70-58.80NA
Q3 2015
11/9/2015
273.00-16.80-67.20NA
Q2 2015
8/7/2015
263.20-18.90-75.60NA
Q1 2015
5/14/2015
308.00-22.40-89.60NA
Q4 2014
6/23/2014
373.80-85.40-341.60NA
Q3 2014
2/14/2014
443.80-57.40-229.60NA
Q2 2014
11/13/2013
392.700.000.00NA
Q1 2014
8/19/2013
523.60-11.90-47.60NA
Adamis Pharmaceuticals PE History Chart
PeriodPriceGAAPTTMPE
Q1 2023
5/15/2023
4.90-4.20-12.60NA
Q4 2022
3/16/2023
8.40-2.10-13.30NA
Q3 2022
11/14/2022
12.60-2.10-14.70NA
Q2 2022
8/10/2022
25.90-4.20-12.60NA
Q1 2022
5/16/2022
32.20-4.90-16.80NA
Q4 2021
3/31/2022
39.90-3.50-28.70NA
Q1 2021
11/22/2021
61.60-8.40-42.70NA
Q4 2020
4/15/2021
51.80-16.80-42.00NA
Q3 2020
11/9/2020
50.40-7.00-30.80NA
Q2 2020
8/17/2020
65.80-10.50-32.20NA
Q1 2020
5/18/2020
39.90-7.70-32.90NA
Q4 2019
3/30/2020
25.90-5.60-38.50NA
Q3 2019
11/12/2019
64.40-8.40-52.50NA
Q2 2019
8/8/2019
67.90-11.20-58.80NA
Q1 2019
5/9/2019
151.20-13.30-67.90NA
Q4 2018
3/15/2019
189.70-19.60-70.70NA
Q3 2018
11/9/2018
194.60-14.70-67.90NA
Q2 2018
8/10/2018
227.50-20.30-67.90NA
Q1 2018
5/10/2018
268.10-16.10-60.90NA
Q4 2017
3/16/2018
269.50-16.80-63.00NA
Q3 2017
11/14/2017
325.50-14.70-42.00NA
Q2 2017
8/14/2017
339.50-13.30-56.00NA
Q1 2017
5/12/2017
262.50-18.20-68.60NA
Q4 2016
3/30/2017
297.504.20-84.00NA
Q3 2016
11/14/2016
203.00-28.70-102.90NA
Q2 2016
8/15/2016
185.50-25.90-91.00NA
Q1 2016
5/13/2016
570.50-33.60-84.00NA
Q4 2015
2/27/2016
NA-14.70-72.80NA
Q3 2015
11/9/2015
273.00-16.80-143.50NA
Q2 2015
8/7/2015
263.20-18.90-184.10NA
Q1 2015
5/14/2015
308.00-22.40-165.20NA
Q4 2014
6/23/2014
373.80-85.40-154.70NA
Q3 2014
2/14/2014
443.80-57.40NANA
Q2 2014
11/13/2013
392.700.00NANA
Q1 2014
8/19/2013
523.60-11.90NANA
Quotes delayed 20 minutes

Email EnvelopeFree ADMP Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Adamis Pharmaceuticals (ADMP) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ADMS PE Ratio History
ADPT PE Ratio History
ADTX PE Ratio History
ADUS PE Ratio History
ADVM PE Ratio History
ADXS PE Ratio History
AEMD PE Ratio History
AERI PE Ratio History
AFIB PE Ratio History
AGEN PE Ratio History
How should the ADMP historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Adamis Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this ADMP Historical PE Ratio page.

What is the average historical PE for ADMP based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The ADMP historical PE ratio using the annualized quarterly earnings method works out to 17.7.

What is the average historical PE for ADMP based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The ADMP historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the Adamis Pharmaceuticals Historical PE Ratio information for Adamis Pharmaceuticals' stock. The average ADMP historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 17.7. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ADMP historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ADMP historical PE result, against the recent PE: when this page was posted on 8/14/2023, the most recent closing price for ADMP had been 1.08, and the most recent quarterly earnings result, annualized, was 16.8. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent ADMP PE on 8/14/2023 based on annualized quarterly EPS was 0.1. Based on ADMP's history, that recent PE is low relative to the historical average, with the recent PE 99.4% lower than the historical average PE across our data set for Adamis Pharmaceuticals.

For self directed investors doing their due diligence on ADMP or any other given stock, valuation analysis for ADMP can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Adamis Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ADMP. Thanks for visiting, and the next time you need to research ADMP Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Republic Services 13F Filers, Top Ten Hedge Funds Holding GDX, LFAC shares outstanding history.

 

Adamis Pharmaceuticals Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 7.8%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 7.8%.